In most studies employing ApoE−/− mice, CRP was found to be neither proatherogenic nor atheroprotective: both passively administered human CRP and transgenically expressed human CRP had no effect on the development, progression, or severity of atherosclerosis (67–71). Here, CRP is linked to atherosclerosis.